摘要
背景:哮喘是一种全球性的健康问题,具有强烈的发病率和对医疗保健系统的重大影响。为制定预防和治疗这种疾病的新策略已经作出了许多努力。鉴于此,本文综述旨在总结儿童哮喘预防和治疗方面的最新进展,重点介绍生命初期最有效的干预措施。 方法:参考文献通过PubMed搜索进行确定。搜索中使用的搜索术语是“小儿哮喘”,“治疗”和“预防”。我们只包括荟萃分析,随机对照试验,综述和系统综述文章,涉及到人类和0-18岁的受试者。所有的干预措施都被归类为“非药理学”和“药理学”。 结果:非药物干预的重点是确定该疾病发病机制的遗传和环境因素,包括个体遗传易感性,早期过敏致敏性,环境微生物组的作用以及接触感染和污染物。此外,现有药理学策略的优化和新治疗方案的开发显着改善了该疾病的治疗,从而降低了医疗费用并改善了患者的生活质量。 结论:儿童哮喘的预防和治疗仍然是一个全球性的挑战。未来的工作应该旨在确定高风险目标人群,最大限度地减少每项干预政策的成本,并加强对治疗策略的遵守。
关键词: 过敏致敏,抗组胺药,抗白三烯,哮喘,儿童期,皮质类固醇,人源化单克隆抗体,免疫治疗。
Current Medicinal Chemistry
Title:Update on Interventions in Prevention and Treatment of Pediatric Asthma
Volume: 25 Issue: 16
关键词: 过敏致敏,抗组胺药,抗白三烯,哮喘,儿童期,皮质类固醇,人源化单克隆抗体,免疫治疗。
摘要: Background: Asthma represents a worldwide health problem with a strong morbidity and a major impact on the health care system. Multiple efforts have been made towards the development of new strategies for the prevention and treatment of this disorder. In the light of this the present review of the literature aimed at summarizing the latest advances in prevention and treatment of pediatric asthma with a focus on the most effective options of interventions during the first stages of life.
Methods: References were identified by searches of PubMed. Search terms used in the search were “pediatric asthma”, “treatment” and “prevention”. We included only meta-analysis, randomized controlled trials, reviews and systematic review articles pertaining to humans and subjects aged 0-18 years. All the interventions have been classified as “non-pharmacological” and “pharmacological”.
Results: Non-pharmacological interventions have been focused in identifying the genetic and environmental factors underlying the pathogenesis of this disease, including the individual genetic susceptibility, the early allergic sensitization, the role of the environmental microbiome and the exposure to infections and to pollutants. Moreover, the optimization of the existing pharmacological strategies and the development of new treatment options have improved markedly the management of this disease, thereby reducing the health care costs and ameliorating the quality of life of patients.
Conclusion: Childhood asthma prevention and treatment still represents a worldwide challenge. Future efforts should be aimed at identifying high risk target populations, minimizing the costs of each policy of intervention and increasing adherence to treatment strategies.
Export Options
About this article
Cite this article as:
Update on Interventions in Prevention and Treatment of Pediatric Asthma, Current Medicinal Chemistry 2018; 25 (16) . https://dx.doi.org/10.2174/0929867324666170303162651
DOI https://dx.doi.org/10.2174/0929867324666170303162651 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Withdrawal Notice: ModStore: Genotype Imputation as a Service Powered by SG10K Reference Panel
Current Bioinformatics Methods for Biomarker Verification and Assay Development
Current Proteomics Medicinal Chemistry Approaches of Controlling Gastrointestinal Side Effects of Non-Steroidal Anti-Inflammatory Drugs. Endogenous Protective Mechanisms and Drug Design
Medicinal Chemistry Protease-Activated Receptors (PARs) are Partly Pro-Inflammatory and Partly Anti-Inflammatory: Will PAR Agonists or Antagonists Participate in Future Drug Therapies?
Current Drug Targets Flavonoids as Potential Anti-Allergic Substances
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Phosphodiesterase 7A: A New Therapeutic Target for Alleviating Chronic Inflammation?
Current Pharmaceutical Design Biotechnological Approaches for the Treatment of Inflammatory Diseases
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Evolving Concepts Concerning Cardiac β-Adrenoceptor Function in Heart Failure
Current Pharmaceutical Design Potential Therapeutic Relevance of Adenosine A2B and A2A Receptors in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Small-molecule Antiviral Agents in Ongoing Clinical Trials for COVID-19
Current Drug Targets Role of Interleukin-21 in Inflammation and Allergy
Inflammation & Allergy - Drug Targets (Discontinued) Natural and Engineered Cystine Knot Miniproteins for Diagnostic and Therapeutic Applications
Current Pharmaceutical Design The Potential of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligands in the Treatment of Hematological Malignancies
Mini-Reviews in Medicinal Chemistry VEGF/VEGFR Pathway Inhibitors as Anti-Angiogenic Agents: Present and Future
Current Cancer Drug Targets The Combined Impact of Exhaled Nitric Oxide and Sputum Eosinophils Monitoring in Asthma Treatment: A Prospective Cohort Study
Current Pharmaceutical Design Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives
Current Pharmaceutical Design Does Inhaled Corticosteroid Treatment Result in a Secondary Immune Deficiency Predisposing To Recurrent Infections?
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mast Cells At Mucosal Frontiers
Current Molecular Medicine Neutrophils and Eosinophils: Clinical Implications of their Appearance, Presence and Disappearance in Asthma and COPD
Current Drug Targets - Inflammation & Allergy Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs
Current Medicinal Chemistry